Blood Pressure (Systolic)-Blood pressure measurements were made before, during and after fetal monitoring of the pregnant women.
| Group | Value | 95% CI |
|---|---|---|
| Intervention 1 | 113.67 | ± 10.06 |
| Intervention 2 | 108.16 | ± 10.56 |
| Control Group | 112.80 | ± 11.21 |
Last reviewed · How we verify
Evaluation of the Effects of Different Positions Given During Antenatal Electro-Fetal Monitoring
NA trial testing Right side lying position in Fetal Monitoring in 305 participants. Completed in 30 November 2022.
| Lead sponsor | Uskudar University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 305 |
| Start date | 30 December 2021 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Uskudar University
Adults 18 to 49, female only, with Fetal Monitoring or Patient Comfort. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Blood Pressure (Systolic)-Blood pressure measurements were made before, during and after fetal monitoring of the pregnant women.
| Group | Value | 95% CI |
|---|---|---|
| Intervention 1 | 113.67 | ± 10.06 |
| Intervention 2 | 108.16 | ± 10.56 |
| Control Group | 112.80 | ± 11.21 |
Blood Pressure (Systolic)
| Group | Value | 95% CI |
|---|---|---|
| Intervention 1 | 110.37 | ± 9.41 |
| Intervention 2 | 107.00 | ± 8.57 |
| Control Group | 108.89 | ± 11.00 |
Blood Pressure (Systolic)
| Group | Value | 95% CI |
|---|---|---|
| Intervention 1 | 115.91 | ± 10.76 |
| Intervention 2 | 100.08 | ± 8.15 |
| Control Group | 113.56 | ± 12.28 |
The objective of this study was to assess the effects of different maternal positions during electronic fetal monitoring (EFM) on maternal and fetal health outcomes. The study was conducted between December 2021 and January 2023 in a maternity hospital in Istanbul, employing a randomized controlled trial design. A total of 240 pregnant women were randomized into three groups: 60 participants were assigned to the right-side lying position (intervention 1), 60 to the semi-sitting position (intervention 2), and 120 to the left-side lying. Maternal systolic blood pressure, body temperature, and pulse rate were measured before, during, and after the EFM procedure. Research data were collected through the Information Form and the General Comfort Scale-Short Form.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05863156.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing